[1] Querfurth HW, LaFerla FM. Alzheimer’s disease[J]. N Engl J Med, 2010, 362(4):329-344.
[2] Alonso Vilatela ME, López-López M, YescasGómez P. Genetics of Alzheimer’s disease [J]. Arch Med Res, 2012,43(8):622-631.
[3] Kim DH, Yeo SH, Park JM, et al. Genetic markers for diagnosis and pathogenesis of Alzheimer’s disease[J]. Gene, 2014,545(2):185-193.
[4] Steinberg S, Stefansson H, Jonsson T, et al. Loss-of-function variants in ABCA7 confer risk of Alzheimer’s disease[J]. Nat Genet, 2015,47(5):445-447.
[5] Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease[J]. Nat Genet, 2013,45(12):1452-1458.
[6] Zuroff L, Daley D, Black KL,et al. Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes[J].Cell Mol Life Sci, 2017, 74(12): 2167-2201.
[7] Abbott NJ, Patabendige AA, Dolman DE, et al. Structure and function of the blood-brain barrier[J]. Neurobiol Dis, 2010, 37(1):13-25.
[8] Villeda SA, Luo J, Mosher KI, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function[J]. Nature, 2011, 477(3762):90-94.
[9] Liu YJ, Guo DW, Tian L, et al. Peripheral T cells derived from Alzheimer’s disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial NF-alpha-dependent[J]. Neurobiol Aging, 2010, 31(2):175-188.
[10]Gosselet F, Saint-Pol J, Candela P, et al. Amyloid-beta peptides, Alzheimer’s disease and the blood-brain barrier[J]. Curr Alzheimer Res, 2013,10(10):1015-1033.
[11]Spector R, Keep RF, Robert SS, et al. A balanced view of choroid plexus structure and function: focus on adult humans[J]. Exp Neurol, 2015,267:78-86.
[12]Chalbot S, Zetterberg H, Blennow K, et al. Blood-cerebrospinal fluid barrier permeability in Alzheimer’s disease[J]. J Alzheimers Dis, 2011,25(3):505-515.
[13]Krzyzanowska A, Carro E. Pathological alteration in the choroid plexus of Alzheimer’s disease: implication for new therapy approaches[J]. Front Pharmacol, 2012,3:75.
[14]Silverberg GD, Mayo M, Saul T, et al. Alzheimer’s disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis[J]. Lancet Neurol, 2003,2(8):506-511.
[15]Gonzalez-Marrero Ⅰ, Gimenez-Llort L, Johanson CE, et al. Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer’s disease[J]. Front Cell Neurosci, 2015,9:17.
[16]Begley DJ, Brightman MW. Structural and functional aspects of the blood-brain barrier[J]. Prog Drug Res, 2003, 61:39-78.
[17]Pardridge WM, Eisenberg J, Yang J. Human blood-brain barrier insulin receptor[J]. J Neurochem, 1985, 44(6):1771-1778.
[18]Zhang Y, Pardridge WM. Rapid transferrin efflux from brain to blood across the blood-brain barrier[J]. J Neurochem, 2001, 76(5):1597-1600.
[19]Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders[J]. Neuron, 2008, 57(2):178-201.
[20]Daneman R. The blood-brain barrier in health and disease[J]. Ann Neurol, 2012,72(5):648-672.
[21]Zhong Z, Deane R, Ali Z, et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration[J]. Nat Neurosci, 2008,11(4):420-422.
[22]Bell RD, Winkler EA, Sagare AP, et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging[J]. Neuron, 2010, 68(3):409-427.
[23]Daneman R, Zhou L, Kebede AA, et al. Pericytes are required for blood-brain barrier integrity during embryogenesis[J]. Nature, 2010, 468(7323):562-566.
[24]Li F, Lan Y, Wang Y, et al. Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch[J]. Dev Cell, 2011,20(3):291-302.
[25]Dziegielewska KM, Ek J, Habgood MD, et al. Development of the choroid plexus[J]. Microsc Res Tech, 2001, 52(1):5-20.
[26]Saunders NR, Daneman R, Dziegielewska KM, et al. Transporters of the bloodbrain and blood-CSF interfaces in development and in the adult[J]. Mol Aspects Med, 2013, 34(2-3):742-752.
[27]Speake T, Whitwell C, Kajita H, et al. Mechanisms of CSF secretion by the choroid plexus[J]. Microsc Res Tech, 2001,52(1):49-59.
[28]de Lange EC. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier[J]. Adv Drug Deliv Rev,2014,56(12):1793-1809.
[29]Bergen AA, Kaing S, ten Brink JB, et al. Gene expression and functional annotation of human choroid plexus epithelium failure in Alzheimer’s disease[J]. BMC Genomics, 2015,16:956.
[30]Serot JM, Béné MC, Foliguet B, et al. Morphological alterations of the choroid plexus in late-onset Alzheimer’s disease[J]. Acta Neuropathol, 2000, 99(2):105-108.
|